Drug plus chemotherapy has been licensed by European regulators . 
  Trials show Avastin gives women four monthsâ€™ extra life . 
  Patients will have access via Cancer Drugs Fund until it is considered for routine NHS use . 
  Each year an estimated 600 women with advanced cervical cancer could benefit from the drug . 
  Nearly 3,000 women are diagnosed with cervical cancer in UK each year . 
 